1-4 of 4
Murray W. Huff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Julia M. Assini, Justin K. Lee, Emma M. Allister, Brian G. Sutherland, Julie B. Koppes, Cynthia G. Sawyez, Jane Y. Edwards, Dawn E. Telford, Alexandre Charbonneau, Philippe St-Pierre, André Marette, Murray W. Huff
Journal: Diabetes
Diabetes 2011;60(5):1446–1457
https://doi.org/10.2337/db10-0589
Published: 23 April 2011
View article titled, Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance
Open the PDF for Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance in another window
Includes: Supplementary data
Journal Articles

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Emma M. Allister, Brian G. Sutherland, Dawn E. Telford, Cynthia G. Sawyez, Jane Y. Edwards, Janet M. Markle, Robert A. Hegele, Murray W. Huff
Journal: Diabetes
Diabetes 2009;58(10):2198–2210
https://doi.org/10.2337/db09-0634
Published: 10 July 2009
View article titled, Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
Open the PDF for Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance in another window
Includes: Supplementary data
Journal Articles

Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes

Emma M. Allister, Nica M. Borradaile, Jane Y. Edwards, Murray W. Huff
Journal: Diabetes
Diabetes 2005;54(6):1676–1683
https://doi.org/10.2337/diabetes.54.6.1676
Published: 01 June 2005
View article titled, Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes
Open the PDF for Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes in another window
Journal Articles

Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation

Nica M. Borradaile, Linda E. de Dreu, Murray W. Huff
Journal: Diabetes
Diabetes 2003;52(10):2554–2561
https://doi.org/10.2337/diabetes.52.10.2554
Published: 01 October 2003
View article titled, Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation
Open the PDF for Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation in another window